ClearSky Medical Diagnostics will be attending the MDS Congress in Philadelphia, USA, from September 27 to October 1, 2024, at booth number 209.
Since its establishment in 2013, ClearSky has been dedicated to providing AI-driven solutions and developing digital tools that support neurologists in tackling the complexities of neurodegenerative diseases in both clinical practice and research. We bridge the gap by offering the AI and machine learning expertise that medical professionals and industry leaders seek but may lack in-house.
One of our flagship innovations, the AI-powered PD-Monitor, offers objective measurements for motor assessments, such as finger tapping and other hand movements. This proprietary device has been deployed in several high-profile clinical studies for Parkinson’s disease and Huntington’s disease, providing clinicians and researchers with reliable, documentable data for tracking motor symptoms.
At ClearSky, we partner with researchers to deliver a holistic service, ranging from protocol design, data collection, and statistical analysis, to the implementation of advanced machine learning techniques. We also offer these services individually, tailored to meet your research and budget needs.
Meet Us at MDS 2024
We invite you to visit booth 209 to meet Prof. Stephen Smith, our AI/ML expert and founder of ClearSky Medical Diagnostics. Learn more about how AI and our cutting-edge solutions can enhance your research or clinical practice.
Highlights at Our Booth:
Live demonstrations of our flagship research tool, PD-Monitor, designed to accurately detect subtle motor symptoms.
A chance to meet our expert team and discuss how our solutions can advance your practice or research.
In-depth information on our ongoing clinical trials and collaborations with leading neurological institutions around the world.
Partner with ClearSky Medical Diagnostics to unlock the full potential of AI and digital technologies in advancing neurodegenerative disease research and patient care.
About the International Parkinson and Movement Disorder Society
The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are interested in movement disorders, including Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.
MDS is the leading professional society for Movement Disorders professionals worldwide, with 11,000+ members dedicated to improving the care through education and research.
For more information about 2024 MDS conference, please visit their official website.
ClearSky: Partner of Choice for AI & ML Solutions in Neurological Conditions
Prof. Smith's participation underscores ClearSky’s commitment to applying AI & ML in neurological research and healthcare practices. ClearSky comprises an interdisciplinary team of world-leading machine learning specialists, clinical experts, and industry professionals. The focus is on exploring future methods for diagnosing and monitoring neurological conditions using clinically-led and validated digital tools and biomarkers.
With over 10 years of experience, ClearSky has developed its own digital solutions and supported investigator-led clinical studies and industry product development efforts.
Stay connected with us for more updates:
Website: www.clearskymd.com
ClearSky - Developing Digital Technologies for Neurodegenerative Disorders
[Keywords]
ClearSky Medical Diagnostics
Stephen Smith
MDS 2024
Neuro AI
AI in neurology
PD-Monitor
motor assessment
finger tapping
Parkinson's disease research
Huntington’s disease research
AI in healthcare
Neurodegenerative diseases
Neurodegenerative disorders
Clinical studies AI
AI-powered medical devices
Machine learning in medicine
Neurological diagnostics
ClearSky Medical Diagnostics
Stephen Smith
MDS 2024
Neuro-AI
Opmerkingen